Clinical Trials Browser

INDUSTRY × exatecan × Gastrointestinal × Clear all

NCT00003951 2012-05-16

DX-8951f in Treating Patients With Metastatic Cancer of the Pancreas

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00004108 2012-05-16

DX-8951f in Treating Patients With Liver Cancer

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00005938 2012-05-16

DX-8951f in Treating Patients With Biliary Cancer

Phase 2 Completed

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00017212 2012-05-16

DX-8951f in Treating Patients With Metastatic Stomach Cancer

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00023972 2012-05-16

Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms